VIVS VivoSim Labs, Inc. - Common Stock
$0,28
Preço · Ago 19, 2026
Fundamentais a partir de Ago 12, 2026
Intervalo 52 Semanas
$0–$5
0% of range
Classificação do Analista
HOLD
7 analysts
Preço-Alvo
—
P/E (TTM)
-0.1
ROE
-294.8%
Margem de Lucro Líquido
-10567.2%
VIVS Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$0.28
Capitalização de Mercado
$797.4K
P/E (TTM)
-0.1
EPS (TTM)
$-5.35
Receita (TTM)
$131.0K
Rendimento div.
—
ROE
-294.8%
Dívida/Capital
—
Intervalo 52 Semanas
$0 – $5
VIVS Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$131.0K
2017-03-31
→
2026-03-31
EPS
$-5.35
2022-03-31
→
2026-03-31
Fluxo de caixa livre
$-11M
2017-03-31
→
2026-03-31
Margens
-10567.2%
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
VIVS
Mediana de Pares
P/E (TTM)
-0.1
—
P/S (TTM)
6.1
48.2
P/B
-0.7
1.5
Price / FCF (Preço / FCF)
-0.1
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
VIVS
Mediana de Pares
Operating Margin (Margem Operacional)
-8768.7%
—
Net Profit Margin (Margem de Lucro Líquido)
-10567.2%
-7380.2%
ROA
-125.6%
-95.1%
ROE
-294.8%
-119.3%
ROIC
1045.4%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
VIVS
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
2.4
3.0
Quick Ratio (Índice de Liquidez Seca)
1.8
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
VIVS
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
-9.0%
—
Revenue CAGR 3Y (CAGR Receita 3A)
-29.3%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
VIVS
Mediana de Pares
VIVS Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
VENDA
7 analistas
- Compra forte 0 0,0%
- Compra 0 0,0%
- Manter 4 57,1%
- Venda 1 14,3%
- Venda forte 2 28,6%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.54%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 31 de Março de 2025 | $-2.21 | $-0.19 | -2.0% |
| 31 de Dezembro de 2024 | $-2.29 | $-2.57 | 0.28% |
| 30 de Setembro de 2024 | $-1.68 | $-3.18 | 1.5% |
| 30 de Junho de 2024 | $-2.76 | $-4.04 | 1.3% |
| 31 de Março de 2024 | $-3.48 | $-5.14 | 1.7% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| VIVS | $4M | -0.3 | -9.0% | -10567.2% | -294.8% | — |
| GOVX | $296.2K | — | -37.1% | -862.3% | -645.9% | — |
| MBIO | — | -2.5 | — | — | -30.9% | — |
| HCWB | — | -0.1 | -97.9% | -14677.1% | -586.8% | 20.0% |
| GRI | $122.9K | -0.0 | — | — | -256.3% | — |
| CRIS | $13M | -1.7 | -13.4% | -80.3% | 177.9% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 17
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $131.0K | $144.0K | $109.0K | $370.0K | $2M | $0 | $2M | $3M | $5M | $4M | $1M | $571.0K | |
| Cost of Revenue | $0 | $5.0K | · | · | · | $0 | $328.0K | $482.0K | $1M | $956.0K | $0 | $0 | |
| R&D Expense | $4M | $5M | $5M | $9M | $3M | $1M | $5M | $15M | $18M | $20M | $18M | $13M | |
| SG&A Expense | $7M | $8M | $10M | $9M | $10M | $16M | $18M | $15M | $21M | $22M | $22M | $18M | |
| Operating Expenses | $12M | $13M | $15M | $18M | $13M | $17M | $24M | $30M | $40M | $43M | $40M | $31M | |
| Operating Income | $-11M | $-13M | $-15M | $-18M | $-11M | $-17M | $-21M | $-27M | $-35M | $-39M | $-39M | $-30M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | $0 | $1.0K | |
| Interest Income | $267.0K | $140.0K | $405.0K | $454.0K | $8.0K | $15.0K | $594.0K | $705.0K | $478.0K | $198.0K | $88.0K | $32.0K | |
| Other Non-op | $-2M | $10M | $417.0K | $474.0K | $25.0K | $6.0K | $2M | $0 | $-12.0K | $0 | $0 | $215.0K | |
| Pretax Income | $-14M | $-2M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $3.0K | $2.0K | $23.0K | $3.0K | $0 | |
| Net Income | $-14M | $-2M | $-15M | $-17M | $-11M | $-17M | $-19M | $-27M | $-35M | $-38M | $-39M | $-30M | |
| EPS (Basic) | $-5.35 | $-1.70 | $-19.25 | $-1.98 | $-1.32 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-5.35 | $-1.70 | $-19.25 | $-1.98 | $-1.32 | · | · | · | · | · | · | · | |
| Shares (Basic) | 2,588,327 | 1,463,609 | 762,076 | 8,713,032 | 8,703,596 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 2,588,327 | 1,463,609 | 762,076 | 8,713,032 | 8,703,596 | · | · | · | · | · | · | · | |
| EBITDA | $-11M | · | · | · | $-11M | · | · | $-26M | $-34M | $-37M | $-38M | $-30M |
Balanço Patrimonial 24
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $11M | $3M | $15M | $29M | $37M | $27M | $36M | $44M | $63M | $62M | $50M | |
| Short-term Investments | · | · | · | · | $0 | · | · | · | · | · | · | · | |
| Receivables | $32.0K | $30.0K | $33.0K | $152.0K | $0 | $0 | $111.0K | $503.0K | $883.0K | $647.0K | $259.0K | $0 | |
| Inventory | · | $0 | $297.0K | $0 | · | · | $0 | $490.0K | $842.0K | $550.0K | $334.0K | $66.0K | |
| Prepaid Expense | $557.0K | $789.0K | $705.0K | $889.0K | $858.0K | $1M | $851.0K | $1M | $1M | $1M | $968.0K | $1M | |
| Other Current Assets | $0 | $12.0K | $4.0K | $69.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $7M | $12M | $4M | $17M | $30M | $38M | $28M | $39M | $47M | $65M | $64M | $51M | |
| PP&E (Net) | $206.0K | $419.0K | $669.0K | $902.0K | $662.0K | $381.0K | $0 | $2M | $3M | $4M | $4M | $2M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $1M | $415.0K | $6M | $7M | $7M | $6M | $3M | |
| Accum. Depreciation | $2M | $2M | $1M | $1M | $1M | $1M | $415.0K | $5M | $4M | $3M | $2M | $1M | |
| Other Non-current Assets | · | · | · | · | · | $1M | $123.0K | $138.0K | $152.0K | $121.0K | $134.0K | $106.0K | |
| Total Assets | $7M | $15M | $6M | $20M | $33M | $40M | $28M | $41M | $50M | $69M | $68M | $53M | |
| Accounts Payable | $1M | $2M | $627.0K | $331.0K | $415.0K | $281.0K | $720.0K | $628.0K | $464.0K | $1M | $787.0K | $1M | |
| Accrued Liabilities | $981.0K | $1M | $727.0K | $3M | $489.0K | $440.0K | $1M | $3M | $3M | $4M | $2M | $2M | |
| Current Liabilities | $3M | $4M | $2M | $4M | $1M | $721.0K | $2M | $4M | $5M | $6M | $4M | $5M | |
| Capital Leases | $0 | $421.0K | $888.0K | $1M | $2M | $0 | · | $0 | · | · | · | $0 | |
| Total Liabilities | $8M | $4M | $3M | $5M | $3M | $721.0K | $2M | $4M | $5M | $7M | $5M | $5M | |
| Common Stock | $3.0K | $2.0K | $1.0K | $9.0K | $9.0K | $9.0K | $7.0K | $124.0K | $111.0K | $104.0K | $92.0K | $82.0K | |
| Retained Earnings | $-356M | $-342M | $-340M | $-325M | $-308M | $-296M | $-279M | $-261M | $-234M | $-199M | $-161M | $-122M | |
| Treasury Stock | $0 | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 | · | · | · | · | · | |
| AOCI | · | · | $0 | $2.0K | $0 | · | · | · | $0 | $-11.0K | $0 | · | |
| Stockholders' Equity | $-1M | $10M | $4M | $15M | $30M | $39M | $27M | $36M | $45M | $62M | $62M | $49M | |
| Liabilities + Equity | $7M | $15M | $6M | $20M | $33M | $40M | $28M | $41M | $50M | $69M | $68M | $53M | |
| Shares Outstanding | 2,894,519 | 1,898,068 | 839,814 | 8,716,906 | 8,710,627 | 8,670,492 | 6,527,905 | 124,015,429 | 111,032,957 | 104,551,466 | 104,551,466 | 81,536,724 |
Fluxo de Caixa 12
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $215.0K | $266.0K | $280.0K | $293.0K | $142.0K | $41.0K | $1M | $980.0K | $1M | $1M | $815.0K | $472.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | · | $7M | $7M | $9M | $7M | |
| Other Non-cash | $3M | · | · | · | $3M | · | · | $5M | $-2M | $721.0K | $-164.0K | $3M | |
| Operating Cash Flow | $-11M | $-9M | $-15M | $-12M | $-8M | $-13M | $-15M | $-20M | $-29M | $-29M | $-29M | $-20M | |
| CapEx | $0 | $13.0K | $42.0K | $396.0K | $409.0K | $405.0K | $0 | $79.0K | $226.0K | $1M | $2M | $2M | |
| Investing Cash Flow | $94.0K | $9M | $816.0K | $-966.0K | $-409.0K | $-393.0K | $747.0K | $-76.0K | $-292.0K | · | · | · | |
| Stock Issued | $5M | $9M | $1M | $0 | $251.0K | $24M | $5M | $13M | $9M | · | · | · | |
| Stock Repurchased | · | · | · | · | $0 | $1.0K | $0 | · | · | · | · | · | |
| Net Stock Activity | $5M | · | · | · | $251.0K | · | · | $13M | · | · | · | · | |
| Financing Cash Flow | $4M | $9M | $1M | $0 | $205.0K | $24M | $5M | $13M | $10M | · | · | · | |
| Net Change in Cash | $-6M | $8M | $-12M | $-13M | $-9M | $10M | $-9M | $-7M | $-19M | $660.0K | $12M | $2M | |
| Free Cash Flow | $-11M | · | · | · | $-9M | · | · | $-20M | $-29M | $-31M | $-31M | $-21M |
Lucratividade 7
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -8768.7% | · | · | · | -765.3% | · | · | -882.4% | -766.3% | -911.9% | -2605.7% | -5305.9% | |
| Net Margin | -10567.2% | · | · | · | -763.2% | · | · | -861.7% | -756.1% | -908.9% | -2601.2% | -5268.3% | |
| Pretax Margin | -10565.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -8604.6% | · | · | · | -755.8% | · | · | -850.7% | -738.7% | -884.8% | -2550.8% | -5223.3% | |
| ROA | -125.6% | · | · | · | -31.3% | · | · | -58.9% | -58.5% | -56.2% | -63.7% | -58.0% | |
| ROE | -294.8% | · | · | · | -33.0% | · | · | -65.9% | -65.1% | -61.7% | -69.6% | -62.0% | |
| ROIC | 1045.4% | · | · | · | · | · | · | · | · | · | · | · |
Liquidez e Solvência 3
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | · | · | · | 21.4 | · | · | 10.3 | 10.0 | 10.8 | 14.2 | 10.8 | |
| Quick Ratio | 1.8 | · | · | · | 20.7 | · | · | 9.9 | 9.6 | 10.5 | 13.9 | 10.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -30297.0 |
Eficiência 3
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | 0.0 | · | · | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.7 | 1.5 | 2.2 | · | · | |
| Receivables Turnover | 4.2 | · | · | · | · | · | · | 4.5 | 6.0 | 9.3 | 11.5 | · |
Taxas de Crescimento 2
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -9.0% | 32.1% | -70.5% | -75.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -29.3% | -54.2% | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $131.0K | $144.0K | $109.0K | $370.0K | $2M | $0 | $2M | $3M | $5M | $4M | $1M | $571.0K | |
| Net Income TTM | $-14M | $-2M | $-15M | $-17M | $-11M | $-17M | $-19M | $-27M | $-35M | $-38M | $-39M | $-30M | |
| Market Cap | $4M | · | · | · | $393M | · | · | $29.47B | $27.45B | $79.79B | $48.12B | $69.27B | |
| P/E | -0.3 | -1.3 | -0.6 | -13.3 | -34.2 | 93.3 | 79.4 | 191.6 | 199.4 | 615.5 | 420.0 | 685.2 | |
| P/S | 31.6 | · | · | · | 262.0 | · | · | 9532.9 | 5962.9 | 18863.8 | 32446.2 | 121319.8 | |
| P/B | -3.8 | · | · | · | 13.0 | · | · | 811.8 | 615.6 | 1279.5 | 773.8 | 1422.6 | |
| P / Tangible Book | · | 0.4 | 34.6 | 14.9 | 13.0 | 25.6 | · | · | · | · | · | · | |
| P / Cash Flow | -0.4 | · | · | · | -46.5 | · | · | -1446.2 | -951.2 | -2734.1 | -1638.4 | -3534.2 | |
| P / FCF | -0.4 | · | · | · | -44.3 | · | · | -1440.6 | -943.8 | -2612.8 | -1528.4 | -3280.3 | |
| Earnings Yield | -374.1% | -75.9% | -155.7% | -7.5% | -2.9% | 1.1% | 1.3% | 0.52% | 0.50% | 0.16% | 0.24% | 0.15% |
Demonstração de Resultados 15
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.0K | $40.0K | $26.0K | $28.0K | $37.0K | $51.0K | $24.0K | $30.0K | $39.0K | $29.0K | $5.0K | $0 | $75.0K | $162.0K | $131.0K | $77.0K | |
| Cost of Revenue | · | $0 | $0 | $0 | $0 | $0 | $2.0K | $1.0K | $2.0K | · | $0 | $0 | $0 | · | · | · | |
| R&D Expense | $1M | $1M | $1M | $923.0K | $1M | $859.0K | $2M | $984.0K | $1M | $1M | $1M | $1M | $2M | $5M | $1M | $1M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | |
| Operating Expenses | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $8M | $3M | $3M | |
| Operating Income | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | $-4M | $-4M | $-8M | $-3M | $-3M | |
| Interest Income | $28.0K | $36.0K | $63.0K | $92.0K | $76.0K | $11.0K | $26.0K | $59.0K | $44.0K | $51.0K | $76.0K | $121.0K | $157.0K | $177.0K | $143.0K | $103.0K | |
| Other Non-op | $1M | $-3M | $59.0K | $92.0K | $72.0K | $10M | $21.0K | $59.0K | $44.0K | $51.0K | $76.0K | $121.0K | $169.0K | $320.0K | $95.0K | $33.0K | |
| Income Tax | $3.0K | $0 | $0 | $2.0K | $0 | $0 | $0 | $0 | $2.0K | $0 | $0 | $0 | $2.0K | $0 | $0 | $0 | |
| Net Income | $-1M | $-6M | $-3M | $-3M | $-3M | $7M | $-3M | $-3M | $-3M | $-3M | $-4M | $-4M | $-4M | $-7M | $-3M | $-3M | |
| EPS (Basic) | $-0.25 | $-2.20 | $-1.03 | $-0.98 | $-1.14 | $5.00 | $-2.28 | $-1.68 | $-2.74 | $-17.93 | $-0.40 | $-0.46 | $-0.46 | $-0.86 | $-0.37 | $-0.38 | |
| EPS (Diluted) | $-0.25 | $-2.20 | $-1.03 | $-0.98 | $-1.14 | $5.00 | $-2.28 | $-1.68 | $-2.74 | $-17.93 | $-0.40 | $-0.46 | $-0.46 | $-0.86 | $-0.37 | $-0.38 | |
| Shares (Basic) | 5,239,462 | -5,128,282 | 2,607,962 | 2,604,950 | 2,503,697 | -2,762,622 | 1,504,713 | 1,499,544 | 1,221,974 | -25,789,113 | 9,115,455 | 8,718,502 | 8,717,232 | -17,423,837 | 8,713,617 | 8,712,284 | |
| Shares (Diluted) | 5,239,462 | -5,128,282 | 2,607,962 | 2,604,950 | 2,503,697 | -2,762,622 | 1,504,713 | 1,499,544 | 1,221,974 | -25,789,113 | 9,115,455 | 8,718,502 | 8,717,232 | -17,423,837 | 8,713,617 | 8,712,284 | |
| EBITDA | $-3M | · | $-3M | $-3M | $-3M | · | $-3M | $-3M | $-3M | · | $-4M | $-4M | $-4M | · | $-3M | $-3M |
Balanço Patrimonial 23
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $5M | $4M | $7M | $9M | $11M | $1M | $3M | $6M | $3M | $5M | $8M | $11M | $15M | $20M | $13M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $10M | |
| Receivables | $29.0K | $32.0K | $33.0K | $32.0K | $32.0K | $30.0K | $26.0K | $29.0K | $48.0K | $33.0K | $33.0K | $55.0K | $149.0K | $152.0K | $76.0K | · | |
| Inventory | · | · | · | · | · | $0 | $0 | $640.0K | $408.0K | $297.0K | · | · | · | $0 | · | · | |
| Prepaid Expense | $511.0K | $557.0K | $709.0K | $882.0K | $592.0K | $789.0K | $913.0K | $940.0K | $640.0K | $705.0K | $913.0K | $624.0K | $792.0K | $889.0K | $788.0K | $519.0K | |
| Other Current Assets | · | $0 | · | · | · | $12.0K | · | · | · | $4.0K | · | · | · | $69.0K | · | · | |
| Current Assets | $3M | $7M | $6M | $8M | $10M | $12M | $2M | $5M | $7M | $4M | $6M | $8M | $12M | $17M | $22M | $24M | |
| PP&E (Net) | $189.0K | $206.0K | $248.0K | $300.0K | $359.0K | $419.0K | $479.0K | $545.0K | $601.0K | $669.0K | $739.0K | $808.0K | $850.0K | $902.0K | $742.0K | $758.0K | |
| PP&E (Gross) | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | |
| Accum. Depreciation | · | $2M | · | · | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Total Assets | $4M | $7M | $7M | $10M | $12M | $15M | $4M | $7M | $9M | $6M | $9M | $11M | $15M | $20M | $25M | $28M | |
| Accounts Payable | $621.0K | $1M | $671.0K | $580.0K | $673.0K | $2M | $930.0K | $419.0K | $1M | $627.0K | $471.0K | $435.0K | $488.0K | $331.0K | $242.0K | $441.0K | |
| Accrued Liabilities | $738.0K | $981.0K | $818.0K | $771.0K | $727.0K | $1M | $1M | $879.0K | $404.0K | $727.0K | $727.0K | $666.0K | $787.0K | $3M | $646.0K | $462.0K | |
| Current Liabilities | $2M | $3M | $2M | $2M | $2M | $4M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $1M | $1M | |
| Capital Leases | $0 | $0 | $44.0K | $172.0K | $298.0K | $421.0K | $543.0K | $660.0K | $775.0K | $888.0K | $999.0K | $1M | $1M | $1M | $1M | $2M | |
| Total Liabilities | $6M | $8M | $3M | $3M | $2M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $3M | $3M | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $17.0K | $15.0K | $14.0K | $1.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | |
| Retained Earnings | $-357M | $-356M | $-350M | $-348M | $-345M | $-342M | $-349M | $-346M | $-343M | $-340M | $-337M | $-333M | $-329M | $-325M | $-318M | $-314M | |
| Treasury Stock | · | $0 | $0 | $0 | $0 | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| AOCI | · | · | · | · | · | · | · | $1.0K | · | · | $1.0K | $1.0K | $2.0K | $2.0K | $3.0K | · | |
| Stockholders' Equity | $-2M | $-1M | $4M | $7M | $10M | $10M | $364.0K | $4M | $7M | $4M | $6M | $8M | $12M | $15M | $22M | $25M | |
| Liabilities + Equity | $4M | $7M | $7M | $10M | $12M | $15M | $4M | $7M | $9M | $6M | $9M | $11M | $15M | $20M | $25M | $28M | |
| Shares Outstanding | 3,194,295 | 2,894,519 | 2,607,962 | 2,607,962 | 2,599,797 | 1,898,068 | 17,133,346 | 15,365,825 | 14,373,076 | 839,814 | 9,838,755 | 8,719,453 | 8,718,203 | 8,716,906 | 8,714,590 | 8,713,268 |
Fluxo de Caixa 11
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $40.0K | $43.0K | $52.0K | $59.0K | $61.0K | $61.0K | $67.0K | $68.0K | $70.0K | $71.0K | $71.0K | $71.0K | $67.0K | $59.0K | $130.0K | $54.0K | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | · | · | |
| Other Non-cash | $-2M | · | · | · | $-1M | · | · | · | $291.0K | · | · | · | $-1M | · | · | · | |
| Operating Cash Flow | $-3M | $-2M | $-2M | $-2M | $-4M | $-2M | $-2M | $-3M | $-3M | $-3M | $-4M | $-3M | $-5M | $-5M | $-3M | $-2M | |
| CapEx | $23.0K | $0 | $0 | $0 | $0 | $0 | $0 | $13.0K | $0 | $0 | $0 | $27.0K | $15.0K | $162.0K | $41.0K | $119.0K | |
| Investing Cash Flow | $-23.0K | $94.0K | $0 | $0 | $0 | $9M | $4.0K | $0 | $20.0K | $13.0K | $27.0K | $12.0K | $764.0K | $-162.0K | $10M | $-86.0K | |
| Stock Issued | $0 | $3M | $0 | $0 | $2M | $3M | $-216.0K | $-371.0K | $6M | $264.0K | $1M | $0 | $0 | $0 | $0 | $0 | |
| Net Stock Activity | $0 | · | · | · | $2M | · | · | · | $6M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-118.0K | $3M | $-118.0K | $0 | $2M | $3M | $-216.0K | $-371.0K | $6M | $264.0K | $1M | $0 | $0 | $0 | $0 | $0 | |
| Net Change in Cash | $-3M | $736.0K | $-2M | $-2M | $-2M | $10M | $-2M | $-3M | $3M | $-2M | $-2M | $-3M | $-5M | $-5M | $7M | $-2M | |
| Free Cash Flow | $-3M | · | · | · | · | · | · | · | $-3M | · | · | · | $-5M | · | · | · |
Lucratividade 5
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -15327.8% | · | -10576.9% | -9410.7% | -7878.4% | · | -14450.0% | -8693.3% | -8682.0% | · | -73600.0% | · | -5593.3% | · | -2564.1% | -4355.8% | |
| Net Margin | -7433.3% | · | -10350.0% | -9089.3% | -7683.8% | · | -14362.5% | -8496.7% | -8574.4% | · | -72080.0% | · | -5370.7% | · | -2491.6% | -4313.0% | |
| EBITDA Margin | -15105.6% | · | -10576.9% | -9410.7% | -7713.5% | · | -14450.0% | -8693.3% | -8502.6% | · | -73600.0% | · | -5504.0% | · | -2564.1% | -4355.8% | |
| ROA | -16.9% | · | -49.8% | -31.0% | -26.5% | · | -54.2% | -28.5% | -27.6% | · | -21.2% | -20.4% | -17.8% | · | -10.8% | -10.4% | |
| ROE | -37.2% | · | -112.0% | -47.4% | -35.1% | · | -105.3% | -42.0% | -36.3% | · | -25.3% | -23.9% | -20.4% | · | -12.2% | -11.2% |
Liquidez e Solvência 2
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | · | 2.4 | 3.1 | 4.5 | · | 0.7 | 2.0 | 3.6 | · | 3.7 | 5.2 | 6.6 | · | 15.7 | 17.5 | |
| Quick Ratio | 0.9 | · | 1.7 | 2.7 | 4.2 | · | 0.4 | 1.3 | 3.1 | · | 3.1 | 4.8 | 6.2 | · | 14.7 | 16.7 |
Eficiência 3
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.6 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.7 | 0.4 | · | 0.1 | 0.0 | 0.6 | · | 3.4 | · |
Avaliação (TTM) 10
| Métrica | Tendência | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $109.0K | · | $115.0K | $119.0K | $130.0K | · | $98.0K | $74.0K | $119.0K | · | $211.0K | $283.0K | $283.0K | · | $208.0K | $77.0K | |
| Net Income TTM | $-9M | · | $-12M | $-11M | $-12M | · | $-13M | $-13M | $-15M | · | $-15M | $-15M | $-14M | · | $-13M | $-14M | |
| Market Cap | $3M | · | $5M | $8M | $4M | · | $95M | $94M | $131M | · | $131M | $131M | $177M | · | $147M | $214M | |
| P/E | -0.3 | · | -0.3 | -0.5 | -0.2 | · | -0.8 | -1.2 | -2.2 | · | -7.9 | -9.0 | -12.8 | · | -11.1 | -15.9 | |
| P/S | 31.4 | · | 41.0 | 64.0 | 29.4 | · | 965.1 | 1270.8 | 1101.5 | · | 621.1 | 462.2 | 624.8 | · | 708.9 | 2783.7 | |
| P/B | -1.5 | · | 1.1 | 1.1 | 0.4 | · | 259.8 | 25.6 | 19.7 | · | 21.2 | 15.5 | 15.0 | · | 6.6 | 8.6 | |
| P / Tangible Book | · | · | 1.1 | 1.1 | 0.4 | · | 259.8 | 25.6 | 19.7 | · | 21.2 | 15.5 | 15.0 | · | 6.6 | 8.6 | |
| P / Cash Flow | -1.1 | · | · | · | -1.0 | · | · | · | -43.9 | · | · | · | -33.3 | · | · | · | |
| P / FCF | -1.1 | · | · | · | · | · | · | · | -43.9 | · | · | · | -33.2 | · | · | · | |
| Earnings Yield | -317.8% | · | -300.0% | -208.2% | -533.3% | · | -128.6% | -86.3% | -44.5% | · | -12.7% | -11.1% | -7.8% | · | -9.0% | -6.3% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| Receita | $131.0K | $144.0K | $109.0K | $370.0K | $2M |
| Margem Operacional % | -8768.7% | — | — | — | -765.3% |
| Lucro líquido | $-14M | $-2M | $-15M | $-17M | $-11M |
| EPS Diluído | $-5.35 | $-1.70 | $-19.25 | $-1.98 | $-1.32 |
Balanço Patrimonial
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 2.4 | — | — | — | 21.4 |
| Índice de Liquidez Seca | 1.8 | — | — | — | 20.7 |
Fluxo de Caixa
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-11M | — | — | — | $-9M |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 27 declarantes · $111K total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 7 (+2 vs trimestre anterior) | 3 (-4 vs trimestre anterior) | 3 (-2 vs trimestre anterior) | 3 (+2 vs trimestre anterior) | +6K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
Executivos da empresa 31 insiders · 14 diretores · 17 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Taylor Crouch | CEO & President | 18 de Agosto de 2020 F | 125.144 | 0 | 0 | $0 |
| Craig Kussman | Chief Financial Officer | 18 de Agosto de 2020 F | 221.743 | 0 | 0 | $0 |
| Barry D Michaels | Chief Financial Officer | 24 de Agosto de 2015 A | 86.808 | 0 | 0 | $0 |
| Murphy Keith | EXECUTIVE CHAIRMAN | 27 de Janeiro de 2026 A | 26.053 | 0 | 0 | $0 |
| Amar Akhtar Sethi | Chief Scientific Officer | 25 de Novembro de 2025 A | — | 0 | 0 | $0 |
| Tony Serge Lialin | Chief Commercial Officer | 11 de Agosto de 2025 A | — | 0 | 0 | $0 |
| Jeffrey N. Miner | Chief Scientific Officer | 31 de Agosto de 2022 A | — | 0 | 0 | $0 |
| Thomas E Jurgensen | General Counsel & Secretary | 31 de Agosto de 2022 A | — | 0 | 0 | $0 |
| Jennifer Bush | General Counsel & Secretary | 18 de Agosto de 2020 F | 192.758 | 0 | 0 | $0 |
| Steven George Hughes | Chief Medical Officer | 16 de Agosto de 2019 S | 138.484 | 0 | 0 | $0 |
| Paul Gallant | General Manager | 16 de Agosto de 2019 F | 191.335 | 0 | 0 | $0 |
| Sharon Collins Presnell | Chief Scientific Officer | 16 de Novembro de 2018 F | 280.993 | 0 | 0 | $0 |
| Eric David | CSO & EVP Pre-Clinical Dev | 16 de Novembro de 2017 F | 876.609 | 0 | 0 | $0 |
| Michael Renard | EVP of Commercial Operations | 4 de Junho de 2015 A | 50.000 | 0 | 0 | $0 |
| David Gobel | Conselheiro | 27 de Janeiro de 2026 A | 15.000 | 0 | 1 | $-7.316 |
| Alison Tjosvold Milhous | Conselheiro | 27 de Janeiro de 2026 A | 19.899 | 0 | 0 | $0 |
| Douglas Jay Cohen | Conselheiro | 27 de Janeiro de 2026 A | 20.732 | 0 | 0 | $0 |
| Adam K Stern | Conselheiro | 27 de Janeiro de 2026 A | 19.899 | 0 | 0 | $0 |
| Vaidehi Joshi | Conselheiro | 7 de Agosto de 2024 A | 58.821 | 0 | 0 | $0 |
| David Shapiro | Conselheiro | 5 de Setembro de 2019 A | — | 0 | 0 | $0 |
| Richard E Maroun | Conselheiro | 5 de Setembro de 2019 A | 15.000 | 0 | 0 | $0 |
| Carolyn Beaver | Conselheiro | 5 de Setembro de 2019 A | — | 0 | 0 | $0 |
| Kirk Malloy | Conselheiro | 5 de Setembro de 2019 A | 7.500 | 0 | 0 | $0 |
| Mark Kessel | Conselheiro | 5 de Setembro de 2019 A | 15.000 | 0 | 0 | $0 |
| Robert Baltera Jr. | Conselheiro | 26 de Julho de 2018 A | 146.006 | 0 | 0 | $0 |
| James T Glover | Conselheiro | 26 de Julho de 2018 A | 17.500 | 0 | 0 | $0 |
| Tamar D Howson | Conselheiro | 26 de Julho de 2018 A | 7.500 | 0 | 0 | $0 |
| Richard A. Heyman | Conselheiro | 20 de Agosto de 2015 A | — | 0 | 0 | $0 |
| Andras Forgacs | Conselheiro | 18 de Outubro de 2012 A | — | 0 | 0 | $0 |
| Chris Heberlig | — | 15 de Setembro de 2020 A | — | 0 | 0 | $0 |
| Kevin Kimberlin | — | 27 de Setembro de 2012 J | — | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 1 ETF
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | — | — | 15 de Julho de 2026 | Diário |